Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to Avanti Biosciences Inc in July, 2019 for $449,436.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AG063560-01 | Phase I | 449,436 | July 1, 2019 | |||||||
A SBIR Phase II contract was awarded to Avanti Biosciences Inc in May, 2019 for $1,321,320.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44AG056181-02 | Phase II | 1,321,320 | May 15, 2019 | |||||||
A SBIR Phase I contract was awarded to Avanti Biosciences Inc in August, 2018 for $298,999.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43DK115229-01A1 | Phase I | 298,999 | August 1, 2018 | |||||||
A SBIR Phase II contract was awarded to Avanti Biosciences Inc in September, 2022 for $976,999.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2SB1AG056181-04 | Phase II | 976,999 | September 30, 2022 | |||||||
A SBIR Phase I contract was awarded to Avanti Biosciences Inc in August, 2017 for $582,601.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44AG056181-01A1 | Phase I | 582,601 | August 15, 2017 | |||||||
A SBIR Phase I contract was awarded to Avanti Biosciences Inc in August, 2023 for $349,235.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43DK134232-01A1 | Phase I | 349,235 | August 1, 2023 |